Filing Details

Accession Number:
0001765581-23-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-06 16:26:06
Reporting Period:
2023-02-02
Accepted Time:
2023-02-06 16:26:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1805688 Samantha Pearce 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Svp, Head Of Europe & Internat No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2023-02-02 531 $109.45 11,840 No 4 M Direct
Ordinary Shares Disposition 2023-02-02 531 $157.26 11,309 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Non-Qualified Stock Option (right to buy) Disposition 2023-02-02 531 $0.00 531 $109.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,907 2030-05-06 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020, 1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter.